These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840 [TBL] [Abstract][Full Text] [Related]
6. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21. Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571 [TBL] [Abstract][Full Text] [Related]
7. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma. Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352 [TBL] [Abstract][Full Text] [Related]
9. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer. Lee DW; Han SW; Kang JK; Bae JM; Kim HP; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY Ann Surg Oncol; 2018 Oct; 25(11):3389-3395. PubMed ID: 30062471 [TBL] [Abstract][Full Text] [Related]
10. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Mima K; Nishihara R; Qian ZR; Cao Y; Sukawa Y; Nowak JA; Yang J; Dou R; Masugi Y; Song M; Kostic AD; Giannakis M; Bullman S; Milner DA; Baba H; Giovannucci EL; Garraway LA; Freeman GJ; Dranoff G; Garrett WS; Huttenhower C; Meyerson M; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S Gut; 2016 Dec; 65(12):1973-1980. PubMed ID: 26311717 [TBL] [Abstract][Full Text] [Related]
11. Fusobacterium and Enterobacteriaceae: important players for CRC? Allen-Vercoe E; Jobin C Immunol Lett; 2014 Dec; 162(2 Pt A):54-61. PubMed ID: 24972311 [TBL] [Abstract][Full Text] [Related]
13. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population. Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057 [TBL] [Abstract][Full Text] [Related]
14. New Roles for Fusobacterium nucleatum in Cancer: Target the Bacteria, Host, or Both? Slade DJ Trends Cancer; 2021 Mar; 7(3):185-187. PubMed ID: 33309240 [TBL] [Abstract][Full Text] [Related]
18. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model. Wu N; Feng YQ; Lyu N; Wang D; Yu WD; Hu YF World J Gastroenterol; 2022 May; 28(18):1981-1995. PubMed ID: 35664967 [TBL] [Abstract][Full Text] [Related]
19. Proteomic characterization of outer membrane vesicles from gut mucosa-derived fusobacterium nucleatum. Liu J; Hsieh CL; Gelincik O; Devolder B; Sei S; Zhang S; Lipkin SM; Chang YF J Proteomics; 2019 Mar; 195():125-137. PubMed ID: 30634002 [TBL] [Abstract][Full Text] [Related]